Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1111/jcmm.15941 http://scihub22266oqcxt.onion/10.1111/jcmm.15941 33009727!7675715!33009727     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       J+Cell+Mol+Med 2020 ; 24 (22): 13542-13545 Nephropedia Template TP {{tp|p=33009727|t=2020. Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID-19?|pdf=|usr=}}{{33009727}} gab.com Text Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID-19 JO: J Cell Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=33009727 #FOAvip Undoubtedly, the new SARS-CoV-2 virus poses a grave health threat, plaguing the health and socio-economic sectors. COVID-19 disease must be treated quickly and effectively as soon as possible. The main axes in this direction are establishing vaccines, drugs, diagnostic tests, as well as identifying the most vulnerable groups. Probably, there is a correlation between COVID-19 and cystic fibrosis. Our interest is focused on cystic fibrosis carriers that, due to limited tests, remain undetectable. There is an activation of the inflammatory response in the carriers, as well as in cystic fibrosis patients. First of all, a striking similarity lies between the inflammatory response in COVID-19 and cystic fibrosis carriers. Notably, ACE-2 plays the same role in both cases and a similar geographical distribution is observed in both diseases. In conclusion, we suggest that cystic fibrosis mutation carriers are potential members of a certain vulnerable group and the detection of such mutations in the population might be vital for the prevention of SARS-CoV-2 virus, and more specifically to limit its serious complications. Twit Text FOAVip Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID-19 ????J Cell Mol Med http://www.kidney.de/pget.php?&tw=1&pmid=33009727 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=33009727 #FOAvip English Wikipedia <ref>{{Cite pmid|33009727}}</ref> Are cystic fibrosis mutation carriers a potentially highly vulnerable group to COVID-19? #MMPMID33009727 Sarantis P; Koustas E; Papavassiliou AG; Karamouzis MV J Cell Mol Med 2020[Nov]; 24 (22): 13542-13545 PMID33009727show ga Undoubtedly, the new SARS-CoV-2 virus poses a grave health threat, plaguing the health and socio-economic sectors. COVID-19 disease must be treated quickly and effectively as soon as possible. The main axes in this direction are establishing vaccines, drugs, diagnostic tests, as well as identifying the most vulnerable groups. Probably, there is a correlation between COVID-19 and cystic fibrosis. Our interest is focused on cystic fibrosis carriers that, due to limited tests, remain undetectable. There is an activation of the inflammatory response in the carriers, as well as in cystic fibrosis patients. First of all, a striking similarity lies between the inflammatory response in COVID-19 and cystic fibrosis carriers. Notably, ACE-2 plays the same role in both cases and a similar geographical distribution is observed in both diseases. In conclusion, we suggest that cystic fibrosis mutation carriers are potential members of a certain vulnerable group and the detection of such mutations in the population might be vital for the prevention of SARS-CoV-2 virus, and more specifically to limit its serious complications. |*Mutation[MESH] |Angiotensin-Converting Enzyme 2/genetics[MESH] |COVID-19/*genetics/mortality/virology[MESH] |Cystic Fibrosis Transmembrane Conductance Regulator/genetics[MESH] |Cystic Fibrosis/epidemiology/*genetics/*virology[MESH] |Genetic Predisposition to Disease[MESH] |Humans[MESH] |Inflammation/genetics/virology[MESH] |SARS-CoV-2/isolation & purification[MESH]Are cystic fibrosis mutation carriers a potentially highly vulnerable (epmc).pdf DeepDyve Pubget Overpricing